Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 3	2026-06-29		NCT05820841

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
Saarland University Medical Center	1
University Hospital Giessen and Marburg	5
University Hospital Regensburg	17
University of Leipzig	51
Universität des Saarlandes	18
Wuerzburg University Hospital	52

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Brüderkrankenhaus St. Josef	Paderborn	Germany	1
Bundeswehrkrankenhaus Ulm	Ulm	Germany	1
CaritasKlinikum Saarbrücken St. Theresia	Saarbrücken	Germany	1
Gemeinschaftspraxis Mohm/Prange-Krex	Dresden	Germany	1
Helios Klinikum Emil von Behring	Berlin	Germany	3
Johannes Wesling Klinikum	Minden	Germany	2
Klinikum Mutterhaus der Borromäerinnen	Trier	Germany	1
Krankenhaus der Barmherzigen Brüder Trier	Trier	Germany	5
MVZ am Klinikum Aschaffenburg	Aschaffenburg	Germany	2
Onkologische Schwerpunktpraxis Kurfürstendamm	Berlin	Germany	1
Rheinland Klinikum-Lukaskrankenhaus Neuss	Neuss	Germany	1
Saarland University Medical Center	Homburg	Germany	4
Städtisches Klinikum Karlsruhe	Karlsruhe	Germany	4
Universitätsklinikum Gießen und Marburg, Standort Gießen	Giessen	Germany	2
Universitätsklinikum Ulm	Ulm	Germany	25
Universitätsmedizin Greifswald	Greifswald	Germany	9
Universitätsmedizin Halle (Saale)	Halle	Germany	1